Verseon Pioneers New Way of Funding Innovation Through Security Token Offering

is launching a security token offering (STO) aiming to set a new
standard for the 21st century public offering to a globally
connected investor base. To make its STO available to investors around
the globe, Verseon will use the technology and services of its
subsidiary BlockRules

Using its innovative, computationally driven drug discovery platform,
clinical-stage pharmaceutical company Verseon has built a rapidly
growing pipeline of unique drug candidates across multiple disease
areas. Verseona??s pipeline includes precision oral anticoagulants
currently in clinical trials, oral treatments for diabetic eye disease,
and next-generation chemotherapy agents, among others. Through its STO,
Verseon is now also pioneering the use of blockchain technology for
funding innovation.

"We believe that blockchain technology has the potential to transform
fundraising by bringing efficiency, cost savings, and additional
liquidity to capital markets,a?? said Eniko Fodor, COO of Verseon.
"Regulations-compliant STOs give companies a new way to support growth
and connect with a global investor community.a??

Because of their global reach, STOs are subject to the regulations of
all the countries where the tokens are sold and traded. Until recently,
no comprehensive solution was available that could enforce complex
regulations in a reliable and transparent manner. BlockRules has solved
this key issue with the BlockRules Compliance
Engine that operates completely on the blockchain for maximum
security and transparency. The Compliance Engine will support the
regulations-compliant issuance, sale, and trading of Verseona??s security
tokens to an international investor base.

Verseona??s security token will be a form of a preferred share that grants
its holder rights to a percentage of the companya??s future drug program
revenues. Initially, Verseon will offer its token in a private sale,
followed by a public token sale.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Ноябрь 2020    »